Allegheny Health Network | Association Partnerships

At Allegheny Health Network (AHN), compassion and innovation meet. We bring together groundbreaking procedures, advanced technology, and the latest research to create new models of care that provide exceptional health care.

To refer a patient call 844-MD-REFER

Connect with us:

Latest from Allegheny Health Network

Predicting Future Treatment Options for Patients With SCLC

January 19, 2023

Video

Gene G. Finley, MD, discusses how he envisions the treatment landscape of small cell lung cancer may evolve over the next 5-10 years.

Samhouri Discusses Practice Changing Data in the DLBCL Space

January 13, 2023

Article

In an interview with Targeted Oncology, Yazan Samhouri, MD, discussed new agents, clinical trials, and developments creating change in diffuse large B-cell lymphoma, as well as the key takeaways from ASH 2022.

Glofitamab Leads to Durable Complete Remissions in Relapsed/Refractory LBCL

January 06, 2023

Article

In an interview with Targeted Oncology, Cyrus M. Khan, MD, further discussed the background of the phase 1/2 trial and the potential use of glofitamab for patients with large B-cell lymphoma in the future.

AHN Brainwaves

November 10, 2022

Article

An update from Allegheny Health Network's Neuroscience Institute.

Lung Cancer Awareness Month: Reducing the Risk of Recurrence of NSCLC

November 03, 2022

Article

In an interview with Targeted Oncology, Benny Weksler, MD, MBA, reviews key trials that have recently influenced the standard of care for patients with stage IB to IIIB NSCLC.

Mao Discusses the Best Management Strategy for a Patient With Clear Cell RCC

October 23, 2022

Article

During a tweet chat, Shifeng S. Mao, MD, PhD and Targeted Oncology Twitter followers discussed the case of 59-year-old woman with clear-cell renal cell carcinoma ad best treatment options for the patient.